Mateon Therapeutics Inc (OXGN) |
|
|
|
EARNINGS REPORT by CSIMarket
Losses Widen but Revenues Unchanged
Mateon Therapeutics Inc announced third quarter 2020 earnings season operating loss of $-1.616273 millions
![closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg) For the third quarter 2020 earnings season Mateon Therapeutics Inc increased losses of $ -0.02 per share compare to $ -0.01 a year ago and eps fell from $0.01 per share from the previous quarter. Sales remained unchanged to $ 0 millions from $0 millions in the same quarter a year ago and sequentially from $1 millions. For the third quarter 2020 earnings season Mateon Therapeutics Inc realized net loss of $ -1.987 million, bigger than $ -0.991 million a year ago.
|
Recently Reported Results |
Flanigans Enterprises Inc
Flanigans Enterprises Inc realized a deterioration in earnings per share by -53.82% to $0.23 and Sales decrease by -2.8% to $28.25 millions in the most recent fiscal period, year on year.
From the preceding quarter, EPS turn positive from $-0.24 per share and Sales improved by 19.36 % from $23.66 millions.
BDL stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Construction Spending
Outlays for U.S. construction projects continue to grow but on the slower pace, mainly because of slow construction spending for lodging.
|
Photronics Inc
In the financial fourth quarter of 2020 Photronics Inc income dropped by -33.33% of $0.10 per share compared to $0.15 a year ago and profit plummeted by -41.18% from $0.17 per share from the previous quarter.
Sales contracted by -4.46% to $149.29 millions from $156.26 millions in the same quarter a year ago and sequentially Sales decreased by -5.45% from $157.90 millions.
PLAB stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Volt Information Sciences Inc
In the financial time frame ending Nov 01 2020 Volt Information Sciences Inc increased losses of $-0.58 per share compared to $-0.04 a year ago and increased losses from $-0.22 per share from the previous quarter.
Sales declined in double digits by -18.32% to $211.07 millions from $258.41 millions in the same quarter a year ago and sequentially Sales advanced by 13.52 % from $185.94 millions.
VOLT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Aehr Test Systems
Aehr Test Systems reported disastrous second quarter of 2020 earnings season, where Sales faded by -75.52% to $1.68 millions and loss per share has widen at $-0.08, from the same quarter a year ago.
Income faded from the preceding quarter from $0.00 per share, Sales fell by -16.35% from $2.01 millions.
AEHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Consumer Price Index
|
Employment Report
The nonfarm payrolls grew 610,000 in November, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,
|
Producer Price Index
U.S. Wholesale prices rose 0.1 % in November, led by growth in food, materials for manufacturing and crude petroleum prices.
|
Greystone Logistics Inc
Company reported strong income growth of 200 % to $0.03 per share, on fading Sales of -20.41% to $15.52 millions in the second quarter of 2020, compared to previous year.
In contrast to the first quarter Sales deteriorated by -11.64% from $17.57 millions and eps remained unchanged from $0.03 per share.
GLGI stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Daybreak Oil and Gas Inc
Daybreak Oil And Gas Inc recorded operating deficit of $-0.095615 millions, in the third quarter of 2020 earnings season, a degradation from the operating loss of $-0.072688 millions, reported in third quarter of 2019
Sales faded by -32.15% to $0.10 millions from $0.14 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.28% from $0.11 millions.
DBRM stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Oramed Pharmaceuticals Inc
In the fiscal period ending Nov 30 2020 Oramed Pharmaceuticals Inc earnings jumped by 53.33 % of $0.23 per share compared to $0.15 a year ago and eps soared by 81.35 % from $0.13 per share from the previous quarter.
Sales remained unchanged by 0% to $0.67 millions from $0.67 millions in the same quarter a year ago and sequentially Sales decreased by -1.03% from $0.68 millions.
ORMP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Semileds Corp
Semileds Corp reported disastrous first quarter of 2020, where Sales faded by -54% to $0.72 millions and loss per share has widen to $-0.17, from the same quarter a year ago.
Eps soared from the preceding quarter from $-0.01 per share, Sales Tumbled by -48.61% from $1.40 millions.
LEDS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Limoneira Company
In the fourth quarter of 2020 earnings season Limoneira Company increased losses of $-0.42 per share compared to $-0.18 a year ago and eps fell from $0.12 per share from the previous quarter.
Sales declined in double digits by -18.38% to $29.77 millions from $36.48 millions in the same quarter a year ago and sequentially Sales Tumbled by -44.41% from $53.56 millions.
LMNR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cannabics Pharmaceuticals Inc
In the fiscal time frame ending Nov 30 2020 Cannabics Pharmaceuticals Inc loss increased of $-0.01 per share compared to $0.04 a year ago and improved from $-0.08 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|